SBI Life Insurance Company Ltd
SBI Life Insurance Company Ltd is engaged in the business of life insurance and annuity. It was started as a Joint-venture between State Bank of India and BNP Paribas Cardif S.A.[1]
- Market Cap ₹ 1,47,818 Cr.
- Current Price ₹ 1,470
- High / Low ₹ 1,936 / 1,307
- Stock P/E 61.3
- Book Value ₹ 166
- Dividend Yield 0.18 %
- ROCE 13.2 %
- ROE 12.0 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Stock is trading at 8.87 times its book value
- Tax rate seems low
- Company has a low return on equity of 12.9% over last 3 years.
- Earnings include an other income of Rs.1,636 Cr.
- Dividend payout has been low at 14.0% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Insurance Industry: Finance & Investments
Part of BSE 100 Nifty 50 Nifty 100 Equal Weight Nifty100 ESG Nifty 500 Multicap 50:25:25
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14,870 | 17,258 | 23,299 | 19,324 | 30,548 | 34,068 | 44,604 | 43,798 | 81,913 | 82,983 | 80,636 | 131,988 | 130,073 | |
14,443 | 16,747 | 22,505 | 18,404 | 29,479 | 32,736 | 43,130 | 42,447 | 81,040 | 82,254 | 80,514 | 131,742 | 129,065 | |
Operating Profit | 427 | 511 | 794 | 920 | 1,068 | 1,332 | 1,474 | 1,351 | 872 | 730 | 122 | 246 | 1,007 |
OPM % | 3% | 3% | 3% | 5% | 4% | 4% | 3% | 3% | 1% | 1% | 0% | 0% | 1% |
292 | 344 | 183 | 129 | 139 | 156 | 266 | 529 | 867 | 1,032 | 1,862 | 1,917 | 1,636 | |
Interest | 4 | 5 | 4 | 5 | 5 | 6 | 8 | 0 | 0 | 0 | 10 | 9 | 0 |
Depreciation | 25 | 35 | 34 | 37 | 48 | 59 | 92 | 89 | 99 | 75 | 68 | 76 | 0 |
Profit before tax | 690 | 816 | 939 | 1,007 | 1,154 | 1,422 | 1,642 | 1,790 | 1,640 | 1,687 | 1,906 | 2,078 | 2,643 |
Tax % | 9% | 11% | 13% | 16% | 17% | 19% | 19% | 21% | 11% | 11% | 10% | 9% | |
630 | 728 | 815 | 844 | 955 | 1,150 | 1,327 | 1,422 | 1,456 | 1,506 | 1,721 | 1,894 | 2,411 | |
EPS in Rs | 6.30 | 7.28 | 8.15 | 8.44 | 9.55 | 11.50 | 13.27 | 14.22 | 14.56 | 15.05 | 17.19 | 18.91 | 24.07 |
Dividend Payout % | 8% | 14% | 15% | 14% | 16% | 17% | 15% | 0% | 17% | 13% | 15% | 14% |
Compounded Sales Growth | |
---|---|
10 Years: | 23% |
5 Years: | 24% |
3 Years: | 17% |
TTM: | 11% |
Compounded Profit Growth | |
---|---|
10 Years: | 9% |
5 Years: | 6% |
3 Years: | 5% |
TTM: | 30% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 9% |
1 Year: | -2% |
Return on Equity | |
---|---|
10 Years: | 16% |
5 Years: | 14% |
3 Years: | 13% |
Last Year: | 12% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,001 | 1,001 | 1,002 |
Reserves | 1,736 | 2,356 | 3,056 | 3,733 | 4,552 | 5,528 | 6,576 | 7,743 | 9,400 | 10,622 | 12,017 | 13,907 | 15,257 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
50,978 | 57,284 | 70,064 | 78,696 | 96,687 | 115,193 | 139,157 | 156,837 | 216,430 | 261,715 | 301,582 | 383,390 | 432,238 | |
Total Liabilities | 53,714 | 60,640 | 74,121 | 83,429 | 102,240 | 121,720 | 146,734 | 165,580 | 226,830 | 273,337 | 314,599 | 398,299 | 448,497 |
283 | 304 | 292 | 301 | 507 | 511 | 563 | 568 | 564 | 919 | 867 | 1,198 | 563 | |
CWIP | 3 | 4 | 7 | 146 | 31 | 70 | 32 | 13 | 1 | 3 | 1 | 6 | 0 |
Investments | 50,047 | 56,275 | 69,385 | 77,843 | 95,830 | 114,436 | 139,325 | 158,813 | 218,756 | 264,437 | 303,988 | 384,943 | 435,926 |
3,382 | 4,058 | 4,437 | 5,139 | 5,871 | 6,703 | 6,814 | 6,186 | 7,509 | 7,978 | 9,743 | 12,152 | 12,009 | |
Total Assets | 53,714 | 60,640 | 74,121 | 83,429 | 102,240 | 121,720 | 146,734 | 165,580 | 226,830 | 273,337 | 314,599 | 398,299 | 448,497 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1,130 | 166 | 2,711 | 5,778 | 8,525 | 10,395 | 13,473 | 19,299 | 23,878 | 21,852 | 28,656 | 29,122 | |
-227 | -708 | -178 | -7,204 | -9,032 | -8,910 | -13,552 | -16,986 | -19,203 | -21,611 | -30,203 | -31,221 | |
-58 | -58 | -117 | -144 | -144 | -221 | -241 | -198 | 3 | -231 | -415 | -227 | |
Net Cash Flow | 845 | -600 | 2,416 | -1,570 | -651 | 1,264 | -321 | 2,114 | 4,677 | 10 | -1,962 | -2,327 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Working Capital Days | -5 | -2 | 0 | -6 | 3 | 3 | 4 | 11 | 1 | -3 | 1 | 4 |
ROCE % | 28% | 27% | 25% | 23% | 23% | 24% | 22% | 22% | 17% | 15% | 15% | 13% |
Documents
Announcements
-
Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The SEBI (LODR) Regulations, 2015
3h - Company received GST demand order and will appeal.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2d - Senior management to meet investors in UAE.
- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 14 Feb
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
5 Feb - Approval for appointment of Chairman and Nominee Director.
-
Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The SEBI (LODR) Regulations, 2015
3 Feb - Company received GST demand order of 39.68 Cr.
Annual reports
Concalls
-
Jan 2025Transcript PPT
-
Oct 2024Transcript PPT
-
Jul 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT
-
Jul 2023Transcript PPT
-
Jun 2023TranscriptNotesPPT
-
May 2023TranscriptPPT
-
Jan 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
Aug 2022TranscriptPPT
-
May 2022TranscriptPPT
-
May 2020TranscriptNotesPPT
-
Jan 2018TranscriptNotesPPT
Product Portfolio
The company offers a range of life insurance products, including 23 individual and 8 group plans across protection, pension, savings, and health solutions. Its portfolio includes participating, non-participating, pension, gratuity, leave encashment, superannuation, annuity, unit-linked, variable, health, and micro-insurance products. [1] [2]